Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Brigitte Dreyfus"'
Autor:
Alice Garnier, Marie Robin, Fabrice Larosa, Jean-Louis Golmard, Steven Le Gouill, Valérie Coiteux, Reza Tabrizi, Claude-Eric Bulabois, Victoria Cacheux, Mathieu Kuentz, Brigitte Dreyfus, Peter Dreger, Bernard Rio, Marie-Pierre Moles-Moreau, Karin Bilger, Jacques-Olivier Bay, Véronique Leblond, Didier Blaise, Olivier Tournilhac, Nathalie Dhédin
Publikováno v:
Haematologica, Vol 95, Iss 6 (2010)
Background Patients with poor-risk Waldenström’s macroglobulinemia have suboptimal response and early post-treatment relapse with conventional therapies. Hence, new therapeutic approaches such as allogeneic stem cell transplantation should be eval
Externí odkaz:
https://doaj.org/article/42d1dd063eef4c60b43b8f2b035cd4a3
Autor:
Pierre Ingrand, Vincent Delwail, A Machet, Stéphanie Guidez, C Debiais-Delpech, Mathieu Puyade, C Laurent, Xavier Leleu, Brigitte Dreyfus, Thomas Systchenko, Gautier Defossez
Publikováno v:
Annals of Hematology. 99:1605-1613
Second primary diffuse large B cell lymphoma (spDLBCL) is defined as a metachronous tumor occurring after a first primary cancer. To date, while R-CHOP is the standard first-line treatment for de novo DLBCL, no available data show that R-CHOP is the
Autor:
Rémi Letestu, Sebastian Böttcher, Petra Langerbeins, Hartmut Döhner, Stefan Ibach, Michael Kneba, Raphaël Porcher, Florence Cymbalista, Anna-Maria Fink, Bruno Cazin, Vincent Levy, Manuela Hoechstetter, Kirsten Fischer, Jasmin Bahlo, Carolin Groß-Ophoff-Müller, Othman Al-Sawaf, Clemens-Martin Wentner, Michael Hallek, Carmen D. Herling, Barbara Eichhorst, Brigitte Dreyfus, Sandra Robrecht, Florian Kaiser, Véronique Leblond, Stéphane Leprêtre, Stephan Stilgenbauer, Raymonde Busch
Publikováno v:
Leukemia
We report a randomized prospective phase 3 study (CLL7), designed to evaluate the efficacy of fludarabine, cyclophosphamide, and rituximab (FCR) in patients with an early-stage high-risk chronic lymphocytic leukemia (CLL). Eight hundred patients with
Publikováno v:
Hématologie. 24:204-206
Autor:
Yse Sauvageon, Brigitte Dreyfus, Thierry Hauet, Raphael Thuillier, Valentin Bossard, François Fraissinet
Publikováno v:
Annales de biologie clinique. 77(4)
A 67 years old woman with a Waldenstrom disease was admitted in the intensive care unit for dyspnea and fever. During hospitalization, episodes of undetectable glycemia were observed without any hypoglycemia symptoms. Plasma glucose was determined wi
Autor:
Vincent Delwail, Isabelle Princet, Gaelle Olivier, Xavier Leleu, Michele Chabin, Laurence Lacotte-Thierry, Jocelyn Barrier, Cécile Tomowiak, Stéphanie Guidez, Céline Debiais-Delpech, Brigitte Dreyfus, Emmanuel Fleck, Anne Corby, Antoine Machet, Joelle Guilhot, Carine Motard, Katell Le Du
Publikováno v:
British Journal of Haematology
Autor:
Mathieu Wemeau, Kamel Laribi, Romain Dubois, Brigitte Dreyfus, Stéphanie Poulain, Cécile Tomowiak, Jehan Dupuis, Frédéric Wallyn, Hélène Demarquette, Héloïse Dapvril, Florence Cymbalista, Charles Herbaux, Jacques-Olivier Bay, Jean-Baptiste Bossard, Franck Morschhauser, Morgane Nudel, Lidwine Wemeau, Stéphane Leprêtre, Fanny Baran-Marszak
Publikováno v:
British Journal of Haematology
British Journal of Haematology, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
British Journal of Haematology, Wiley, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
British Journal of Haematology, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
British Journal of Haematology, Wiley, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
International audience; No abstract available
Autor:
Eric Jourdan, Kalaivani Veerabudun, Brigitte Dreyfus, Yazid Arkam, Chahinez Benkanoun, Sylvain Choquet, Alain Delmer, Abdelaziz Chaib, Sophie Gandon, Kun Lun Liu, Lionel Karlin, Olivier Fitoussi, Stéphane Leprêtre, H. Orfeuvre, Marc Maynadié, Marie-Sarah Dilhuydy, Omar Benbrahim, Frédéric Boissard, Borhane Slama, Adrian Tempescul, Jean Luc Labourey, Driss Chaoui, Laurent Voillat, Maya Hacini, Laurence Sanhes, Marly Barry, Beatrice Mahe
Publikováno v:
Leukemialymphoma. 60(6)
Chronic lymphocytic leukemia (CLL) is the most prevalent type of adult leukemia in Western countries [1]. Despite advances in chemo-immunotherapy, most CLL patients relapse after the first-line che...
Publikováno v:
Hématologie. 24:340-341
Autor:
Julie Lejeune, Carole Soussain, Xavier Leleu, Brigitte Dreyfus, Caroline Dartigeas, Véronique Leblond, Stéphane Leprête, Sylvie Chevret, Marie-Sarah Dilhuidy, Anne Banos, Thérèse Aurran, Brigitte Pegourie, Olivier Tournilhac, Herve Oya, Beatrice Mahe, Bruno Anglaret, Caroline Besson, Anne Vekhoff, Pierre Morel, Maya Ouzegdouh
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. 〈10.1080/10428194.2017.1307357〉
Leukemia & lymphoma, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. 〈10.1080/10428194.2017.1307357〉
Leukemia & lymphoma, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
In patients with advanced Waldenström macroglobulinemia (WM), overall response rate (ORR) and median progression-free survival (PFS) achieved with bortezomib alone and bortezomib rituximab combination were 27-85% and 7.9 months, and 81% and 16.4 mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f17c36bc619884109a0b417760710e1
https://hal.archives-ouvertes.fr/hal-01655961
https://hal.archives-ouvertes.fr/hal-01655961